Park Ha Biological Technology Co. Ltd. Class A (BYAH)
NASDAQ: BYAHConsumer DiscretionaryPackage Goods/CosmeticsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
BYAH stock chart
Technical analysisKey statistics
All statistics- Market cap
- $16.59M
- EPS (TTM)
- -$37.68
- Dividend yield
- None
- 52-week range
- 0.85 – 112.00
- Day range
- 0.85 – 1.12
- Volume / Avg
- 55.16K / 193.24K
- Beta
- —
- Shares outstanding
- 19.46M
52-week range
BYAH stock today
Shares of Park Ha Biological Technology (BYAH) finished lower on Nov 20 at $0.8501, a drop of 18.26% or $0.1899 per share, versus the S&P 500's 3.70% decline. Trading was light, with 55.16K shares changing hands, about 29% of the average daily volume. At this level, BYAH sits near the bottom of its 52-week range of $0.85 to $112.00: 99.2% below the high and 0.0% above the low.
Park Ha Biological Technology has posted a net loss over the last twelve months (EPS of -$37.68), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Park Ha Biological Technology
Company profilePark Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. It operates in two segments, Product Sales and Franchise Service. The company offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand.
- Sector
- Consumer Discretionary
- Industry
- Package Goods/Cosmetics
- CEO
- Ms. Xiaoqiu Zhang
- Headquarters
- Wuxi
- Employees
- 41
- IPO year
- 2024
- Website
- parkha.cn
Financial highlights
Full financialsIn fiscal 2025, Park Ha Biological Technology generated $2.5 million in revenue, up 6.0% from fiscal 2024. Park Ha Biological Technology reported a net loss of $24.4 million, compared with net income of $478,561 a year earlier. Gross margin was 94.4% (up from 91.8%) and operating margin -956.5%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Revenue | $2.52M | $2.38M | $2.46M | $1.92M |
| Growth | +6.00% | -3.14% | +28.12% | — |
| Net income | $-24.36M | $478.56K | $852.04K | $191.30K |
| EPS (diluted) | $-41.38 | $0.96 | $1.70 | $0.01 |
Park Ha Biological Technology peers
Consumer Discretionary sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CABRCaring Brands Inc. | 0.66 | 0.00% | $7.59M | vs BYAH |
| YCBDcbdMD Inc. | 0.36 | -5.11% | $4.84M | vs BYAH |
| BIOTInstinct Bio Technical Company Holdings Inc. | 0.1432 | -12.15% | $4.12M | vs BYAH |
| AXILAXIL Brands Inc. | 4.27 | -5.22% | $29.13M | vs BYAH |
| BNKKBonk Inc. | 0.4558 | -3.41% | $3.91M | vs BYAH |
| UGUnited-Guardian Inc. | 7.35 | +4.11% | $33.77M | vs BYAH |
| WNWMeiwu Technology Company Limited | 1.65 | -13.42% | $43.31M | vs BYAH |
| SLSNSolesence Inc. | 1.41 | -4.73% | $99.61M | vs BYAH |
Indexes, lists and sector
Largest Consumer Discretionary stocks
Park Ha Biological Technology stock FAQ
What is Park Ha Biological Technology's stock price today?
BYAH last traded at $0.8501 as of Nov 20, 4:00 PM EST, down 18.26% on the day. Prices are delayed at least 15 minutes.
Who is Park Ha Biological Technology's CEO?
Ms. Xiaoqiu Zhang is the chief executive officer of Park Ha Biological Technology Co. Ltd. Class A, which has about 41 employees.
What is the BYAH 52-week high?
The 52-week high for BYAH is $112.00 and the 52-week low is $0.85. The stock is currently 99.2% below its high.